GCM
EVH icon

Graham Capital Management’s Evolent Health EVH Stock Holding History

Graham Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$417K Sell
76,924
-106,623
-58% -$409K 0.01% 775
2026
Q1 		$418K Buy
183,547
+41,788
+29% +$133K 0.01% 692
2025
Q4 		$567K Buy
141,759
+80,156
+130% +$446K 0.01% 583
2025
Q3 		$521K Buy
+61,603
New +$598K 0.01% 596
2025
Q2 		– Sell
-19,062
Closed -$181K – 1377
2025
Q1 		$181K Sell
19,062
-26,532
-58% -$268K ﹤0.01% 1152
2024
Q4 		$513K Buy
+45,594
New +$801K 0.01% 728
2024
Q3 		– Sell
-82,423
Closed -$1.58M – 1163
2024
Q2 		$1.58M Buy
82,423
+28,905
+54% +$738K 0.03% 295
2024
Q1 		$1.75M Buy
53,518
+37,035
+225% +$1.18M 0.03% 273
2023
Q4 		$544K Buy
+16,483
New +$466K 0.01% 568
2023
Q1 		– Sell
-19,719
Closed -$554K – 1133
2022
Q4 		$554K Sell
19,719
-10,135
-34% -$291K 0.02% 736
2022
Q3 		$1.07M Buy
29,854
+12,041
+68% +$424K 0.04% 454
2022
Q2 		$547K Buy
17,813
+7,095
+66% +$207K 0.02% 643
2022
Q1 		$346K Buy
+10,718
New +$281K 0.01% 689

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Graham Capital Management's EVH Position: Q2 2026 in Review

Graham Capital Management reduced its Evolent Health (EVH) stake by 58% in Q2 2026, selling an estimated $409K and leaving 76,924 shares worth $417K. The position accounts for 0.01% of the portfolio, ranked #775.

Graham Capital Management first reported a position in EVH in Q1 2022 and has held it in 13 quarters since. The position peaked at $1.75M in Q1 2024. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Graham Capital Management held 76,924 shares of Evolent Health worth $417K as of Q2 2026.
  • Graham Capital Management sold 106,623 Evolent Health shares in Q2 2026, an estimated $409K.
  • Evolent Health made up 0.01% of Graham Capital Management's portfolio in Q2 2026, its #775 holding.
  • Graham Capital Management first reported a position in Evolent Health in Q1 2022 and has held it in 13 quarters since.
  • Graham Capital Management's Evolent Health position peaked at $1.75M in Q1 2024.
  • 199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.